Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Prostaglandin D2 receptor 2 | ||
Ligand | BDBM50401104 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_884446 (CHEMBL2212208) | ||
IC50 | >1000±n/a nM | ||
Citation | Kaila, N; Huang, A; Moretto, A; Follows, B; Janz, K; Lowe, M; Thomason, J; Mansour, TS; Hubeau, C; Page, K; Morgan, P; Fish, S; Xu, X; Williams, C; Saiah, E Diazine indole acetic acids as potent, selective, and orally bioavailable antagonists of chemoattractant receptor homologous molecule expressed on Th2 cells (CRTH2) for the treatment of allergic inflammatory diseases. J Med Chem55:5088-109 (2012) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Prostaglandin D2 receptor 2 | |||
Name: | Prostaglandin D2 receptor 2 | ||
Synonyms: | CD_antigen=CD294 | CRTH2 | Chemoattractant Receptor-homologous molecule expressed on T-helper type 2 cells (CRTH2) | Chemoattractant receptor-homologous molecule expressed on Th2 cells | Chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2) | DL1R | G protein-coupled receptor 44 | G-protein coupled receptor 44 | GPR44 | PD2R2_HUMAN | PTGDR2 | Prostaglandin D2 | Prostaglandin D2 receptor 2 | Prostaglandin D2 receptor 2 (PGD2) | ||
Type: | Enzyme | ||
Mol. Mass.: | 43295.45 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q9Y5Y4 | ||
Residue: | 395 | ||
Sequence: |
| ||
BDBM50401104 | |||
n/a | |||
Name | BDBM50401104 | ||
Synonyms: | CHEMBL2205152 | ||
Type | Small organic molecule | ||
Emp. Form. | C28H26N4O2 | ||
Mol. Mass. | 450.5316 | ||
SMILES | CN(C)C(=O)Cn1c(C)c(-c2nn(Cc3ccccc3)c(=O)c3ccccc23)c2ccccc12 |(15.98,-25.02,;16.46,-26.48,;15.43,-27.63,;17.97,-26.8,;18.44,-28.27,;19,-25.65,;18.52,-24.19,;19.43,-22.93,;20.97,-22.93,;18.52,-21.68,;19.29,-20.35,;20.83,-20.36,;21.61,-19.03,;23.15,-19.04,;23.91,-20.38,;23.13,-21.7,;23.89,-23.03,;25.43,-23.04,;26.21,-21.7,;25.44,-20.37,;20.84,-17.7,;21.62,-16.37,;19.3,-17.69,;18.53,-16.35,;16.98,-16.36,;16.21,-17.71,;16.99,-19.04,;18.53,-19.03,;17.04,-22.16,;15.71,-21.4,;14.38,-22.17,;14.38,-23.71,;15.71,-24.48,;17.04,-23.71,)| | ||
Structure |